-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Ligand Pharmaceuticals Inc quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2016 to 2023.
- Ligand Pharmaceuticals Inc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $59K.
- Ligand Pharmaceuticals Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $288K, a 79.8% decline from 2022.
- Ligand Pharmaceuticals Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $1.43M, a 52.8% decline from 2021.
- Ligand Pharmaceuticals Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $3.03M, a 32.2% decline from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)